SERB Pharmaceuticals acquired the target/assets from Charterhouse Capital Partners in a take-private transaction.
Deal value was 2900000000 Sector: Life Sciences; Location: USA.
On the acquirer side, legal advice was provided by a team including Paul Humphreys, Sebastian Fain, Jeff Jay, Wicy Wang, Sahara Baker, Arash Ardalan, Simon Trisk, Ben Cohen, Dr. Zackory Burns, Juliana Zhang, Wolfgang Paulson, Lori Goodman, Jordan Salzman, Jordan Riley, Aled Batey, Richard Daniels, Christina Banz, Kelsey Pepper, Michael Levitt, Stephanie Brown Cripps, Young Park, Christine Chong.
Generated by AI, original source from - Data is in progress
Charterhouse Capital Partners advisor
Firm name is in progress
Found it useful? Spread the word.
Freshfields advises SERB Pharmaceuticals on take-private of Y-mAbs Therapeutics, Inc. | The Sponsor - The Sponsor
